Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Estimation of exponential rates in non-homogeneous populations using the EAIR estimator.

Journal of biopharmaceutical statistics·2026

Same author

The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis.

Kidney international·2025

Same author

Estimand Framework and Statistical Considerations for Integrated Analysis of Clinical Trial Safety Data.

Therapeutic innovation & regulatory science·2024

Same author

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data.

Statistics in medicine·2024

Same author

Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical data.

Clinical trials (London, England)·2023

Same author

Quantitative MRI Biomarkers as Potential Inclusion Body Myositis Clinical Trial Endpoints.

Neurology·2022

Search research articles

Related Experiment Video

Updated: May 19, 2026

High-throughput, Microscale Protocol for the Analysis of Processing Parameters and Nutritional Qualities in Maize (Zea mays L.)

High-throughput, Microscale Protocol for the Analysis of Processing Parameters and Nutritional Qualities in Maize (Zea mays L.)

Published on: June 16, 2018

Superchain procedures in clinical trials with multiple objectives.

George Kordzakhia¹, Alex Dmitrienko

¹U.S. Food and Drug Administration, Silver Spring, MD, U.S.A. george.kordzakhia@fda.hhs.gov

Statistics in Medicine

|August 21, 2012

Summary

This summary is machine-generated.

This study presents superchain procedures, a novel method for clinical trial multiple testing. These flexible procedures enhance power and simplify analysis for trials with grouped objectives.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain

Published on: March 13, 2020

Related Experiment Videos

Last Updated: May 19, 2026

High-throughput, Microscale Protocol for the Analysis of Processing Parameters and Nutritional Qualities in Maize (Zea mays L.)

High-throughput, Microscale Protocol for the Analysis of Processing Parameters and Nutritional Qualities in Maize (Zea mays L.)

Published on: June 16, 2018

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain

Published on: March 13, 2020

Area of Science:

Biostatistics
Clinical Trial Methodology
Statistical Inference

Background:

Multiple testing is a significant challenge in clinical trials, particularly with grouped objectives like co-primary or primary/secondary endpoints.
Existing multiple testing procedures, such as chain and parallel gatekeeping procedures, have limitations in flexibility and power optimization.
The need for adaptable and efficient statistical methods is crucial for robust clinical trial analysis.

Purpose of the Study:

To introduce a new class of multiple testing procedures, termed superchain procedures.
To extend existing multiple testing frameworks to accommodate complex clinical trial objectives grouped into families.
To provide a flexible and powerful methodology for addressing multiplicity in clinical trials.

Main Methods:

Development of superchain procedures, an extension of chain and parallel gatekeeping procedures.
Incorporation of distributional information to enhance statistical power.
Design of flexible decision rules tailored to various win criteria in confirmatory trials.
Illustration of the methodology with clinical trial examples involving two and three families of objectives.

Main Results:

Superchain procedures offer flexible decision rules adaptable to diverse win criteria.
The methodology allows for efficient incorporation of distributional information, improving overall trial power.
The testing algorithms associated with superchain procedures are straightforward, facilitating implementation.
Successful application demonstrated in clinical trial scenarios with multiple families of objectives.

Conclusions:

Superchain procedures provide a valuable advancement in multiple testing methodology for clinical trials.
The flexibility and power enhancements offered by superchain procedures can lead to more efficient trial designs.
The straightforward nature of the algorithms supports the practical adoption of superchain procedures in clinical research.